Concepedia

Neil Henderson

NH

Statistics

Publications

9

Citations

412

H-Index

9

Active since

2012

Affiliations

AstraZeneca (Sweden)(Current)

Bristol-Myers Squibb (United States)

Sanofi (United States)

Pfizer (United States)

Health Canada

Neil Henderson is an author at AstraZeneca (Sweden) specializing in pharmacy, bioanalytical methodology, and bioanalytical method validation.

ORCID

Publications per year

2012–2023

9

Publications

9

pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function

Julian Philipp, Aleksandra P. Dabkowska, Anita Reiser et al. · Proceedings of the National Academy of Sciences · 2023 · 127 citations · Full text

, , +17

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti et al. · Bioanalysis · 2019 · 95 citations · Full text

, , +13

European Bioanalysis Forum Recommendation on Method Establishment And Bioanalysis of Biomarkers in Support of Drug Development

Philip Timmerman, Christian Herling, Daniela Stoellner et al. · Bioanalysis · 2012 · 59 citations

, , +11

2018 White Paper on Recent Issues in Bioanalysis: <i>‘A Global Bioanalytical Community Perspective on Last Decade of Incurred Samples Reanalysis (ISR)’</i> (Part 1 – Small Molecule Regulated Bioanalysis, Small Molecule Biomarkers, Peptides &amp; Oligonucleotide Bioanalysis)

Jan Welink, Yuanxin Xu, Eric Yang et al. · Bioanalysis · 2018 · 39 citations · Full text

, , +16

2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid &amp; Rare Matrices; Regulatory Inputs ( <u>Part 1A</u> – Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC &amp; <u>Part 1B</u> - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene &amp; Cell Therapy and Vaccine)

Surinder Kaur, Stephen C. Alley, Matt Szapacs et al. · Bioanalysis · 2022 · 29 citations · Full text

, , +15

1–5 of 9